Reimagining cancer care with real-world evidence: an interview with Stephanie Reisinger, Flatiron

Written by Stephanie Reisinger (Flatiron)
Artificial intelligence and machine learning Health equity Interviews Oncology and hematology Real-world evidence
Image of Stephanie Reisinger on a green and purple background, next to the title: Reimagining cancer care with real-world evidence: an interview with Stephanie Reisinger, Flatiron. To show that this is about Stephanie Reisinger discusses reimagining cancer care with RWE.

Real-world evidence (RWE) is being leveraged to inform decision-making across the spectrum of health care. In the field of oncology, insights from the analysis of real-world data (RWD) can be used to understand the complexities ​of​ care and shape the way for new treatment approaches. In this interview we speak with Stephanie Reisinger, Senior Vice President and General Manager, Real-World Evidence at Flatiron Health to understand more about the evolving role of RWE in cancer research and care.  Please could you introduce yourself and your background?  I’m Stephanie Reisinger, the Senior Vice President and General Manager at Flatiron for RWD...

To view this content, please register now for access

It's completely free